El perfil de seguridad de los nuevos GLP-1 es favorable, aunque es fundamental monitorizar los posibles efectos adversos y ajustar las dosis segn las necesidades del paciente
Prevention Strategies : Gradual tapering, healthy lifestyle choices like moderate carb intake, exercise, and sleep prioritization
Notably, p300 is one of the most frequently studied AR-associated coregulators in CaP
however, these symptoms were mild to moderate in their intensity and were most often reported during dose escalation
If the remaining Phase 3 readouts hold and the FDA filing proceeds on the projected late- 2026 timeline, retatrutide is positioned to arrive as the unambiguous class leader and the first obesity drug whose efficacy curve starts to genuinely overlap with bariatric surgery
Munnangi SR, Youssef AAA, Narala N, Lakkala P, Narala S, Vemula SK, Repka M (2023) Drug complexes: perspective from academic research and pharmaceutical market